| Definium Therapeutics, Inc. | 281K | US$13.2M | 3.1% |
| Mbx Biosciences, Inc. | 211K | US$11.6M | 2.7% |
| Alumis Inc. | 326K | US$9.17M | 2.1% |
| Ataibeckley Inc. | 1.73M | US$9.11M | 2.1% |
| Trevi Therapeutics, Inc. | 488K | US$9.1M | 2.1% |
| Enliven Therapeutics, Inc. | 177K | US$8.97M | 2.1% |
| Amylyx Pharmaceuticals, Inc. | 486K | US$8.72M | 2.0% |
| Veradermics, Incorporated | 70,310 | US$8.64M | 2.0% |
| Ligand Pharmaceuticals Incorporated | 26,334 | US$8.32M | 1.9% |
| Nuvation Bio Inc. | 1.43M | US$8.11M | 1.9% |
| Edgewise Therapeutics, Inc. | 199K | US$8.07M | 1.9% |
| Nektar Therapeutics | 115K | US$8.04M | 1.9% |
| Liquidia Corporation | 100K | US$7.99M | 1.9% |
| Maze Therapeutics, Inc. | 266K | US$7.93M | 1.9% |
| Harrow, Inc. | 182K | US$7.73M | 1.8% |
| Eyepoint, Inc. | 530K | US$7.58M | 1.8% |
| Amneal Pharmaceuticals, Inc. | 427K | US$7.39M | 1.7% |
| Ocular Therapeutix, Inc. | 748K | US$7.35M | 1.7% |
| Corcept Therapeutics Incorporated | 83,688 | US$7.28M | 1.7% |
| Crinetics Pharmaceuticals, Inc. | 190K | US$7.13M | 1.7% |
| Pacira Biosciences, Inc. | 279K | US$7.08M | 1.7% |
| Merck & Company, Inc. | 54,900 | US$7.05M | 1.6% |
| Indivior Pharmaceuticals, Inc. | 172K | US$7.04M | 1.6% |
| Elanco Animal Health Incorporated | 286K | US$7.04M | 1.6% |
| Johnson & Johnson | 27,417 | US$6.96M | 1.6% |
| Eli Lilly And Company | 5,757 | US$6.91M | 1.6% |
| Jazz Pharmaceuticals Plc | 28,473 | US$6.86M | 1.6% |
| Collegium Pharmaceutical, Inc. | 188K | US$6.8M | 1.6% |
| Bristol-myers Squibb Company | 118K | US$6.78M | 1.6% |
| Supernus Pharmaceuticals, Inc. | 145K | US$6.74M | 1.6% |
| Royalty Pharma Plc | 120K | US$6.72M | 1.6% |
| Tarsus Pharmaceuticals, Inc. | 107K | US$6.72M | 1.6% |
| Wave Life Sciences Ltd. | 1.16M | US$6.71M | 1.6% |
| Harmony Biosciences Holdings, Inc. | 184K | US$6.71M | 1.6% |
| Organon & Co. | 489K | US$6.62M | 1.5% |
| Ani Pharmaceuticals, Inc. | 79,881 | US$6.61M | 1.5% |
| Viatris Inc. | 415K | US$6.58M | 1.5% |
| Esperion Therapeutics, Inc. | 2.08M | US$6.58M | 1.5% |
| Axsome Therapeutics, Inc. | 26,541 | US$6.5M | 1.5% |
| Innoviva, Inc. | 284K | US$6.46M | 1.5% |
| Bioage Labs, Inc. | 262K | US$6.43M | 1.5% |
| Prestige Consumer Healthcare Inc. | 133K | US$6.29M | 1.5% |
| Rapport Therapeutics, Inc. | 148K | US$6.16M | 1.4% |
| Pfizer, Inc. | 255K | US$6.15M | 1.4% |
| Omeros Corporation | 641K | US$6.1M | 1.4% |
| Perrigo Company Plc | 585K | US$6.08M | 1.4% |
| Xeris Biopharma Holdings, Inc. | 753K | US$5.97M | 1.4% |
| Zoetis Inc. | 80,428 | US$5.78M | 1.3% |
| Eton Pharmaceuticals, Inc. | 154K | US$5.59M | 1.3% |
| Phibro Animal Health Corporation | 175K | US$5.5M | 1.3% |
| Amphastar Pharmaceuticals, Inc. | 266K | US$5.36M | 1.3% |
| Arvinas, Inc. | 643K | US$5.34M | 1.2% |
| Zevra Therapeutics, Inc. | 369K | US$5.3M | 1.2% |
| Alto Neuroscience, Inc. | 190K | US$5.02M | 1.2% |
| Phathom Pharmaceuticals, Inc. | 420K | US$4.55M | 1.1% |
| Relmada Therapeutics, Inc. | 655K | US$4.53M | 1.1% |
| Cormedix Inc. | 550K | US$4.32M | 1.0% |
| Septerna, Inc. | 127K | US$4.24M | 0.99% |
| Theravance Biopharma, Inc. | 241K | US$4.1M | 0.96% |
| Aclaris Therapeutics, Inc. | 724K | US$3.83M | 0.89% |
| Lb Pharmaceuticals Inc | 105K | US$3.41M | 0.80% |
| Aquestive Therapeutics, Inc. | 788K | US$3.28M | 0.76% |
| Fulcrum Therapeutics, Inc. | 808K | US$2.96M | 0.69% |
| Lexicon Pharmaceuticals, Inc. | 1.12M | US$2.69M | 0.63% |
| Evolus, Inc. Common Stock | 325K | US$2.26M | 0.53% |
| Terns Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |